Healthcare Company's Stock Spikes In Volume: Announces Acquisition & Expansion To AI Web Data
XTL Biopharmaceuticals Leverages AI in Healthcare with The Social Proxy Acquisition.
In an unexpected yet strategic move,XTL Biopharmaceuticals Ltd (NASDAQ: XTLB)announced its acquisition of The Social Proxy, a decision that has sent ripples through both the biopharmaceutical and tech industries. This acquisition not only marks XTL's ambitious expansion into the AI and web data sphere but also significantly increases their intellectual property (IP) portfolio, promising to redefine the landscape of healthcare innovation.$XTL Biopharmaceuticals (XTLB.US)$